Use of Fourier-domain OCT to detect retinal nerve fiber layer degeneration in Parkinson's disease patients

Eye (Basingstoke)

Volumn 27, Issue 4, 2013, Pages 507-514

  Satue, M ^a,b   Garcia Martin, E ^a,b   Fuertes, I ^a,b   Otin, S ^a   Alarcia, R ^a   Herrero, R ^a,b   Bambo, M P ^a,b   Pablo, L E ^a,b   Fernandez, F J ^a,b  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^b INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

Author keywords

biomarker; degeneration; optical coherence tomography; Parkinson's disease; retinal nerve fiber layer

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; CLINICAL EXAMINATION; COLOR VISION TEST; CONTROLLED STUDY; FEMALE; FOURIER DOMAIN OPTICAL COHERENCE TOMOGRAPHY; HUMAN; INFERIOR TEMPORAL CORTEX; MACULAR THICKNESS; MAJOR CLINICAL STUDY; MALE; OPTICAL COHERENCE TOMOGRAPHY; PARKINSON DISEASE; RADIODIAGNOSIS; RETINA FOVEA; RETINAL NERVE FIBER LAYER THICKNESS; RETINAL THICKNESS; STATISTICAL SIGNIFICANCE; VISUAL ACUITY;

EID: 84876142550     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2013.4     Document Type: Article

References (31)

1. Park A, Stacy M. Non-motor symptoms in Parkinson's disease. J Neurol 2009; 256(Suppl 3): 293-298.
2. Braak H, Del Tredici K, Bratzke H, Hamm-Clement J, Sandmann-Keil D, Rüb U. Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages). J Neurol 2002; 249(Suppl 3): III/1-III/5.
3. Bodis-Wollner I. Retinopathy in Parkinson disease. J Neural Transm 2009; 116(11): 1493-1501.
4. Bodis-Wollner I, Yahr MD, Mylin LH, Thornton J. Dopaminergic deficiency and delayed visual evoked potentials in humans. Ann Neurol 1982; 11(5): 478-483.
5. Moschos MM, Tagaris G, Markopoulos I, Margetis I, Tsapakis S, Kanakis M et al. Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss. Eur J Ophthalmol 2011; 21(1): 24-29.
6. Schuman JS, Pedut-Kloizman T, Hertzmark E, Hee MR, Wilkins JR, Coker JG et al. Reproducibility of nerve fibre layer thickness measurements using optical coherence tomography. Ophthalmology 1996; 103(11): 1889-1898.
7. Palace J. Inflammation versus neurodegeneration: consequences for treatment. J Neurol Sci 2007; 259: 46-49.
8. Hauser SL, Oksenberg JR. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 2006; 52: 61-76.
9. Sá MJ. Physiopathology of symptoms and signs in multiple sclerosis. Arq Neuropsiquiatr 2012; 70(9): 733-740.
10. Garcia-Martin E, Pueyo V, Pinilla I, Ara JR, Martin J, Fernandez J. Fourier-domain OCT in multiple sclerosis patients: reproducibility and ability to detect retinal nerve fiber layer atrophy. Invest Ophthalmol Vis Sci 2011; 52(7): 4124-4131.
11. Hajee ME, March WF, Lazzaro DR, Wolintz AH, Shrier EM, Glazman S et al. Inner retinal layer thinning in Parkinson disease. Arch Ophthalmol 2009; 127(6): 737-741; Erratum in: Arch Ophthalmol 2009;127(12): 1615.
12. Cubo E, Tedejo RP, Rodriguez Mendez V, López Peña MJ, Trejo Gabriel Y, Galán JM. Retina thickness in Parkinson's disease and essential tremor. Movement Disorders 2010; 25: 2461-2477.
13. Aaker GD, Myung JS, Ehrlich JR, Mohammed M, Henchcliffe C, Kiss S. Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography. Clin Ophthalmol 2010; 4: 1427-1432.
14. Bodis-Wollner I, Spund B, Liu T, Shrier E, Selesnick I, Glazman S et al. Remodeling of the fovea in Parkinson disease. Invest Ophthalmol Vis Sci 2011; 52(E-Abstract): 6660.
15. Rohani M, Langroodi AS, Ghourchian S, Falavarjani KG, Soudi R, Shahidi G. Retinal nerve changes in patients with tremor dominant and akinetic rigid Parkinson's disease. Neurol Sci 2012; e-pub ahead of print 3 June 2012; doi:10.1007/s10072-012-1125-7.
16. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease. A clinico-pathological study of 100 cases. Neurodegener Dis 2010; 7(5): 284-290.
17. Reichmann H. Clinical criteria for the diagnosis of Parkinson's disease. Neurodegenerative Dis 2010; 7: 284-290.
18. De Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol 2006; 5: 525-535.
19. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967; 17(5): 427-442.
20. Gupta PK, Asrani S, Freedman SF, El-Dairi M, Bhatti MT. Differentiating glaucomatous from non-glaucomatous optic nerve cupping by optical coherence tomography. Open Neurol J 2011; 5: 1-7.
21. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report No. 1 1985; 103: 1796-1806.
22. Inzelberg R, Ramirez JA, Nisipeanu P, Ophir A. Retinal nerve fiber layer thinning in Parkinson disease. Vision Res 2004; 44(24): 2793-2797.
23. Altintaş O, Işeri P, Ozkan B, Caǧlar Y. Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease. Doc Ophthalmol 2008; 116(2): 137-146.
24. La Morgia C, Barboni P, Rizzo G, Carbonelli M, Savini G, Scaglione C et al. Loss of temporal retinal nerve fibers in Parkinson disease: a mitochondrial pattern? Eur J Neurol 2013; 20: 198-201.
25. Archibald NK, Clarke MP, Mosimann UP, Burn DJ. Retinal thickness in Parkinson's disease. Parkinsonism Relat Disord 2011; 17(6): 431-436.
26. Sung KR, Wollstein G, Bilonick RA, Townsend KA, Ishikawa H, Kagemann L et al. Effects of age on optical coherence tomography measurements of healthy retinal nerve fiber layer, macula, and optic nerve head. Ophthalmology 2009; 116(6): 1119-1124.
27. Garcia-Martin E, Pueyo V, Ara J, Almarcegui C, Martin J, Pablo L et al. Effect of optic neuritis on progressive axonal damage in multiple sclerosis patients. Mult Scler 2011; 17(7): 830-837.
28. Garcia-Martin E, Pablo LE, Herrero R, Satue M, Polo V, Larrosa JM et al. Diagnostic ability of a linear discriminant function for Spectral domain optical coherence tomography in multiple sclerosis patients. Ophthalmology 2012; 119(8): 1705-1711.
29. Kesler A, Vakhapova V, Korczyn AD, Naftaliev E, Neudorfer M. Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Clin Neurol Neurosurg 2011; 113(7): 523-526.
30. Shrier EM, Adam CR, Spund B, Glazman S, Bodis-Wollner I. Interocular asymmetry of foveal thickness in Parkinson disease. J Ophthalmol 2012; 2012: 728457.
31. Nakatani Y, Higashide T, Ohkubo S, Takeda H, Sugiyama K. Evaluation of macular thickness and peripapillary retinal nerve fiber layer thickness for detection of early glaucoma using spectral domain optical coherence tomography. J Glaucoma 2011; 20(4): 252-259.